DAINO, Lucia Maria Elisa
 Distribuzione geografica
Continente #
NA - Nord America 1.089
EU - Europa 706
AS - Asia 457
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.260
Nazione #
US - Stati Uniti d'America 1.068
CN - Cina 288
UA - Ucraina 266
SG - Singapore 119
DE - Germania 101
SE - Svezia 100
IT - Italia 60
FI - Finlandia 47
FR - Francia 44
GB - Regno Unito 37
CZ - Repubblica Ceca 28
TR - Turchia 28
CA - Canada 20
BE - Belgio 13
IR - Iran 8
IN - India 5
KR - Corea 4
LT - Lituania 4
AU - Australia 3
EU - Europa 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PA - Panama 1
RO - Romania 1
Totale 2.260
Città #
Chandler 290
Jacksonville 161
Singapore 103
Princeton 82
Dearborn 70
Nanjing 58
Wilmington 43
Ann Arbor 39
Sassari 38
Nanchang 36
Boardman 27
Woodbridge 27
Brno 26
Beijing 25
Izmir 24
Shenyang 21
Changsha 17
Shanghai 16
Tianjin 16
Brussels 13
Toronto 13
Hebei 12
Santa Clara 12
Zhengzhou 12
Jiaxing 11
Ningbo 11
London 10
Munich 10
Norwalk 10
Augusta 9
Hangzhou 9
Jinan 9
Dallas 8
Guangzhou 8
Leawood 8
Ardabil 7
Helsinki 7
San Mateo 7
Ottawa 6
Taizhou 6
Falls Church 5
Kunming 5
Los Angeles 5
Monmouth Junction 5
Mountain View 5
Auburn Hills 4
Frankfurt am Main 4
New York 4
San Francisco 4
Seoul 4
Andover 3
Ashburn 3
Cagliari 3
Changchun 3
Grézieu-la-varenne 3
Torino 3
Berlin 2
Canberra 2
Hefei 2
Olomouc 2
Rome 2
Tappahannock 2
Alghero 1
Auckland 1
Bridlington 1
Brierley Hill 1
Cedar Knolls 1
Chalfont 1
Chicago 1
Chittagong 1
Dhaka 1
Dubai 1
Edinburgh 1
Edmonton 1
Haifa 1
Huntington 1
Lanzhou 1
Panama City 1
Pune 1
Raleigh 1
Romola 1
Shijiazhuang 1
Sofia 1
Stockholm 1
São Paulo 1
Tallinn 1
Wuhan 1
Xi'an 1
Xian 1
Zurich 1
Totale 1.420
Nome #
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 89
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 81
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 78
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 68
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 66
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 64
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 63
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 62
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 62
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 61
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 60
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 59
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 59
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 59
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 59
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 58
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 58
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 58
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 57
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 57
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 57
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 56
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 55
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 55
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 55
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 55
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 54
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 53
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 52
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 51
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 51
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 50
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 49
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 48
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 47
Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat 44
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 41
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 41
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 39
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 36
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 30
Totale 2.297
Categoria #
all - tutte 12.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 0 0 0 0 0 58 105 9 48 19 46 2
2020/2021389 43 1 58 3 40 18 44 1 54 57 58 12
2021/2022220 42 1 0 3 8 3 13 11 17 21 21 80
2022/2023505 54 48 10 91 42 88 0 56 87 1 14 14
2023/2024126 34 9 1 2 13 3 0 3 0 0 13 48
2024/2025227 7 16 59 52 61 32 0 0 0 0 0 0
Totale 2.297